Eye Research Center, The five Senses Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Eye (Lond). 2023 Jun;37(8):1519-1526. doi: 10.1038/s41433-022-02230-z. Epub 2022 Sep 10.
Cystoid macular oedema (CMO), which is defined as a macular thickening and cystic changes due to accumulation of fluid, could be asymptomatic and only diagnosed using paraclinical techniques. Fluorescein angiography (FA) and optical coherence tomography (OCT) are useful in detecting CMO in clinical practice. Non-leaking CMO, also known as angiographically silent CMO, is referred to as cases of CMO without leakage in fluorescein angiography. This type of CMO has been reported in some retinal dystrophies, in cases of maculopathy as a side effect of certain drugs, and also in some systemic disorders. The exact mechanism and treatment options for this type of CMO are still not clear. This literature review aims to discuss different causes of non-leaking CMO, proposed mechanisms, and management options. Three sections including drugs, retinal dystrophies, and systemic disorders are discussed in this review.
黄斑囊样水肿(cystoid macular oedema,CMO)是指由于液体积聚导致的黄斑增厚和囊样改变,可能无症状,仅通过辅助检查技术诊断。荧光素血管造影(fluorescein angiography,FA)和光学相干断层扫描(optical coherence tomography,OCT)在临床实践中有助于检测 CMO。非渗漏性 CMO,也称为无荧光素渗漏性 CMO,是指 FA 检查中无渗漏的 CMO 病例。这种类型的 CMO 已在一些视网膜营养不良、某些药物引起的黄斑病变以及一些系统性疾病中报道过。这种 CMO 的确切机制和治疗选择仍不清楚。本文旨在讨论非渗漏性 CMO 的不同病因、提出的机制和治疗选择。本文从药物、视网膜营养不良和系统性疾病三个方面进行了综述。